- Home
- PGC vs FDMT Comparison
PGC vs FDMT Comparison
Compare PGC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGC | FDMT |
|---|---|---|
| Founded | 1921 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.6M | 695.3M |
| IPO Year | 1997 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PGC | FDMT |
|---|---|---|
| Price | $43.26 | $12.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $56.00 | $28.09 |
| AVG Volume (30 Days) | 113.0K | ★ 1.0M |
| Earning Date | 11-06-2026 | 11-09-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | 13.51 | ★ 18.79 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $282,995,000.00 | $85,209,000.00 |
| Revenue This Year | $24.36 | N/A |
| Revenue Next Year | $12.76 | $55.65 |
| P/E Ratio | $26.42 | ★ N/A |
| Revenue Growth | 24.05 | ★ 230194.60 |
| 52 Week Low | $24.71 | $6.96 |
| 52 Week High | $49.14 | $16.93 |
Technical Indicators
Market Signals| Indicator | PGC | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 37.71 | 38.81 |
| Support Level | $42.23 | $8.43 |
| Resistance Level | $44.07 | $14.00 |
| Average True Range (ATR) | 0.89 | 0.84 |
| MACD | -0.07 | -0.20 |
| Stochastic Oscillator | 33.77 | 15.04 |
Price Performance
Historical ComparisonAbout PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).